Perspectives for immunotherapy of EBV ‐associated GLELC: A relatively “hot” tumor microenvironment
ConclusionCompared with GAC, EBVaGLELC revealed higher T cell infiltration and less intense of angiogenesis. It displays relatively “hot” TME that may provide the rationality to treat with immunotherapy in EBV-related GLELC.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Yanna Lei,
Peng Cao,
Xiufeng Zheng,
Jing Wei,
Mo Cheng,
Ming Liu Tags: RESEARCH ARTICLE Source Type: research
More News: Adenocarcinoma | Allergy & Immunology | Cancer | Cancer & Oncology | Carcinoma | China Health | Gastric (Stomach) Cancer | Gastroenterology | Immunotherapy | Rare Diseases | Study